Search
for
Sort by
Research 151–180 of 230
- Pathological Mechanisms Involved in Epidermolysis Bullosa Simplex: Current Knowledge and Therapeutic Perspectives
- A Systematic Review of 207 Studies Describing Validation Aspects of the Dermatology Life Quality Index
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Cardiovascular Disease-Associated Skin Conditions
- A Review of the Most Common Dermatologic Conditions and their Debilitating Psychosocial Impacts
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Immune therapies for alopecia areata: evidence and new perspectives
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Retrospective analysis of smell and taste disturbances associated with dermatologic medications reported to the United States Food and Drug Administration and relevance to COVID-19 infections
- Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Hidradenitis suppurativa: A comparison of guidelines
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Spironolactone in hidradenitis suppurativa: a single-center
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Teledermatology Service During the COVID-19 Pandemic in China: A Mobile Application-Based Retrospective Study
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- The Effectiveness of a Topical Rosehip Oil Treatment on Facial Skin Characteristics: A Pilot Study on Wrinkles, UV Spots Reduction, Erythema Mitigation, and Age-Related Signs
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study
- Microneedling combined with compound betamethasone in treatment of severe alopecia areata: A case report
- Alopecia areata – Aktuelles Verständnis und Management
- Sustaining treatment response in alopecia areata through tofacitinib dose tapering: A single-center retrospective study
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Depressive Disorder and Dermatological Autoimmune Diseases